Učitavanje...
Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
Background: Vitamin K antagonists have been the treatment of choice in preventing thromboembolic events, but problems such as frequent dose adjustment and monitoring of coagulation status, including multiple drug and food interactions, make their use difficult. Dabigatran etexilate is a new oral dir...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2013-06-01
|
| Serija: | Pharmacy Practice |
| Teme: | |
| Online pristup: | http://www.pharmacypractice.org/journal/index.php/pp/article/view/340 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|